C-cell hyperplasia of the thyroid
The VA rates C-cell hyperplasia of the thyroid under Diagnostic Code 7919 at a single 0% level. With a cap of 0%, most veterans pursue secondary conditions to increase their combined rating.
Rating schedule — DC 7919 at a glance
- Minimum rating
- 0%
- Maximum rating
- 0%
- Rating tiers
- 1
- CFR section
- § 4.119
- Body system
- Endocrine System
- Secondary conditions
- 0
Lowest schedular rating available
TDIU may raise effective compensation to 100%
0%
Part 4 rating schedule
None mapped
What are the VA rating criteria for C-cell hyperplasia of the thyroid?
| Rating | Criteria |
|---|---|
| 0% | If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903. Note: Cross-reference — see referenced criteria for rating tiers |
“If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903.”
Common Questions About C-cell hyperplasia of the thyroid VA Ratings
What is the VA rating range for C-cell hyperplasia of the thyroid?
The VA rates C-cell hyperplasia of the thyroid under Diagnostic Code 7919 at 0%. The minimum 0% rating requires: If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903.. The maximum 0% rating requires: If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903..
Which 38 CFR diagnostic code does the VA use for C-cell hyperplasia of the thyroid?
The VA rates C-cell hyperplasia of the thyroid under Diagnostic Code (DC) 7919, governed by 38 CFR 38 CFR § 4.119. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.
Can C-cell hyperplasia of the thyroid qualify for TDIU?
C-cell hyperplasia of the thyroid maxes at 0%, well below the single-disability TDIU threshold. However, combined with other service-connected disabilities, TDIU may be achievable under 38 CFR § 4.16. Focus on establishing secondary conditions to increase the combined rating.
What evidence supports a higher rating for C-cell hyperplasia of the thyroid?
The key evidence for C-cell hyperplasia of the thyroid is documentation of how the condition affects daily functioning. Treatment records showing worsening symptoms, functional limitations documented by your provider, and buddy statements describing observable impact on daily life all strengthen the claim. A nexus letter from a qualified medical professional linking the current severity to service is essential for contested claims.
What happens at the C&P exam for C-cell hyperplasia of the thyroid?
The C&P examiner uses a Endocrine System DBQ and evaluates your condition against the DC 7919 rating criteria. The examiner documents symptom frequency, severity, and functional impact. Bring all treatment records and describe your worst days, not your best — the VA rates on the full clinical picture across time, not a snapshot of one good day.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits